Document ID: chunk:federal_register_of_legislation:F2023L00940:reg:9:p1
Version: federal_register_of_legislation:F2023L00940
Segment Type: reg
Provision Reference: reg 9 (pt 1/6)
Character Range: 4510–7516

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting peripheral neuropathy or death from peripheral neuropathy with the circumstances of a person's relevant service:
(1)          having amyloidosis at the time of the clinical onset of peripheral neuropathy;
Note: amyloidosis is defined in the Schedule 1 – Dictionary.
(2)          having chronic liver disease at the time of the clinical onset of peripheral neuropathy;
(3)          having chronic renal failure at the time of the clinical onset of peripheral neuropathy;
Note: chronic renal failure is defined in the Schedule 1 – Dictionary.
(4)          having sarcoidosis at the time of the clinical onset of peripheral neuropathy;
(5)          having an endocrine disease from the specified list of endocrine diseases at the time of the clinical onset of peripheral neuropathy;
Note: specified list of endocrine diseases is defined in the Schedule 1 – Dictionary.
(6)          having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical onset of peripheral neuropathy;
Note: specified list of autoimmune diseases is defined in the Schedule 1 – Dictionary.
(7)          having a systemic vasculitis from the specified list of forms of systemic vasculitis at the time of the clinical onset of peripheral neuropathy;
Note: specified list of forms of systemic vasculitis is defined in the Schedule 1 – Dictionary.
(8)          having an infection from the specified list of infections at the time of the clinical onset of peripheral neuropathy;
Note: specified list of infections is defined in the Schedule 1 – Dictionary.
(9)          having a haematological or lymphoproliferative disorder from the specified list of haematological or lymphoproliferative disorders at the time of the clinical onset of peripheral neuropathy;
Note: specified list of haematological or lymphoproliferative disorders is defined in the Schedule 1 – Dictionary.
(10)      having a malignant neoplasm, other than non-melanotic malignant neoplasm of the skin, at the time of the clinical onset of peripheral neuropathy;
(11)      having a neurological paraneoplastic syndrome at the time of the clinical onset of peripheral neuropathy;
(12)      having a critical illness within the 30 days before the clinical onset of peripheral neuropathy;
Note: critical illness is defined in the Schedule 1 – Dictionary.
(13)      having severe alcohol use disorder at the time of the clinical onset of peripheral neuropathy;
Note: severe alcohol use disorder is defined in the Schedule 1 – Dictionary.
(14)      consuming at least 200 kilograms of alcohol within the 10 years before the clinical onset of peripheral neuropathy;
Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(15)      inhaling, ingesting or having cutaneous contact with